Pages Tagged With: "Prelude Therapeutics"
Prelude Therapeutics raises $60 million in new funding round
Prelude Therapeutics, a Wilmington-based, clinical-stage pharmaceutical company, raised $60 million in a recently closed Series B funding round, the company announced. The $60 million raised brings to $90 million the amount the company has raised to date, Prelude Therapeutics said in a press release. Prelude Therapeutics develops small molecule drugs that target the growth of cancer cells. The […]
